Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
4.765
+0.025 (0.53%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Sensus Healthcare Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Sensus Healthcare stock have an average target of 13, with a low estimate of 12 and a high estimate of 14. The average target predicts an increase of 172.82% from the current stock price of 4.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sensus Healthcare stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +151.84% | Apr 4, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +172.82% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $12 | Strong Buy | Maintains | $11 → $12 | +151.84% | Feb 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +130.85% | Nov 18, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +193.81% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
42.62M
from 41.81M
Increased by 1.93%
Revenue Next Year
56.04M
from 42.62M
Increased by 31.49%
EPS This Year
0.33
from 0.41
Decreased by -18.40%
EPS Next Year
0.62
from 0.33
Increased by 85.58%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 50.8M | 65.2M | 70.2M | ||
| Avg | 42.6M | 56.0M | 64.1M | ||
| Low | 30.0M | 48.5M | 57.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.6% | 53.0% | 25.4% | ||
| Avg | 1.9% | 31.5% | 14.3% | ||
| Low | -28.3% | 13.8% | 2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.58 | 0.89 | 0.92 | ||
| Avg | 0.33 | 0.62 | 0.58 | ||
| Low | 0.03 | 0.23 | 0.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 41.7% | 168.4% | 49.7% | ||
| Avg | -18.4% | 85.6% | -5.8% | ||
| Low | -92.8% | -32.2% | -58.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.